High Prevalence of a BRCA1 Gene Founder Mutation, 5083del19, in Unselected Breast–ovarian Cancer Patients From Southern Italy: Genotype–phenotype Correlations

Breast Cancer Research - United Kingdom
doi 10.1186/bcr1091
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genotype–phenotype Correlation in BRCA1/2 Mutation-Associated Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

Prevalence of the BRCA1 Founder Mutation C.5266dupin Brazilian Individuals At-Risk for the Hereditary Breast and Ovarian Cancer Syndrome

Hereditary Cancer in Clinical Practice
OncologyGenetics
2011English

Analysis of Clinical Characteristics of Breast Cancer Patients With the Japanese Founder Mutation BRCA1 L63X

Oncotarget
Oncology
2019English

Sensitivity of BRCA1/2 Mutation Testing in 466 Breast/Ovarian Cancer Families

Journal of Medical Genetics
Genetics
2003English

Founder BRCA1/2 Mutations Among Male Patients With Breast Cancer in Israel

American Journal of Human Genetics
Genetics
1999English

Prevalence of BRCA1 and BRCA2 Mutations in Breast Cancer Patients From Brazil

Breast Cancer Research and Treatment
Cancer ResearchOncology
2006English

A Novel BRCA1 Mutation in a Patient With Breast and Ovarian Cancer: A Case Report

Oncology Letters
Cancer ResearchOncology
2013English

BRCA1 (185delAG) Mutation Among Egyptian Breast Cancer Female Patients

Journal of High Institute of Public Health
2008English

Founder BRCA1/2 Mutations in the Europe: Implications for Hereditary Breast-Ovarian Cancer Prevention and Control

EPMA Journal
BiochemistryHealth PolicyDrug Discovery
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy